Carl Gordon Insider Profile
39 Followers
Carl Gordon, Director, Ten Percent Owner at ADARx Pharmaceuticals, holds 588.24K shares in ADARx Pharmaceuticals (Ticker: ADRX), holds 1.76M shares in Electra Therapeutics Inc. (Ticker: ETRA), holds 1.35M shares in Scribe Therapeutics Inc. (Ticker: SCTX).
Carl Gordon ADARx Pharmaceuticals (ADRX)Director, Ten Percent Owner
ADARx Pharmaceuticals (ADRX)
Director, Ten Percent Owner
Ranked #57,678 out of 109,287 Corporate Insiders
Profitable Transactions
14 out of 32 Profitable Transactions
Average Return
-0.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Carl Gordon holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Feb 19, 2025 - Feb 19, 2026
Return:+232.00%
The most profitable trade made by Carl Gordon
Carl Gordon's Trading History
ADARx Pharmaceuticals
Sep 30, 2026
Director, Ten Percent Owner
Uninformative Buy
―
$10.56M
Pacira Pharmaceuticals
Feb 10, 2011
Director
Informative Buy
13.33M
$102.95M
Intellia Therapeutics
―
Director
―
―
X4 Pharmaceuticals
Nov 20, 2017
Director
Informative Buy
5.00M
$6.26M
Armo Biosciences Inc
Jun 22, 2018
―
Uninformative Sell
205.95M
$0.00
Alector
Feb 11, 2019
Director, Ten Percent Owner
Uninformative Buy
―
$457.20K
Turning Point Therapeutics
Apr 24, 2019
―
Informative Buy
6.48M
$154.11M
Prevail Therapeutics
Jun 26, 2019
―
Uninformative Buy
―
$317.92M
Keros Therapeutics
Dec 18, 2025
Director
Uninformative Sell
3.81M
$523.11K
Oric Pharmaceuticals
Mar 31, 2021
Director, Ten Percent Owner
Uninformative Sell
2.43M
$20.58M
Adicet Bio
Jun 07, 2024
Director, Ten Percent Owner
Uninformative Buy
―
$43.66M
Kinnate Biopharma
Apr 05, 2024
―
Uninformative Sell
―
$0.00
Terns Pharmaceuticals
Jul 17, 2024
―
Informative Sell
561.64K
$40.01M
Disc Medicine
―
Director, Ten Percent Owner
―
―
Theseus Pharmaceuticals
Feb 14, 2024
―
Uninformative Sell
―
$0.00
Compass Therapeutics
Apr 11, 2025
Director
Informative Sell
5.68M
$11.57M
ArriVent BioPharma, Inc.
Jan 31, 2024
Director, Ten Percent Owner
Uninformative Buy
―
$23.81M
MBX Biosciences, Inc.
Feb 19, 2025
Director, Ten Percent Owner
Informative Buy
2.02M
$40.51M
Scribe Therapeutics Inc.
Jul 29, 2026
Director
Uninformative Buy
―
$23.66M
BlossomHill Therapeutics, Inc.
Aug 12, 2026
Director
Uninformative Buy
―
$44.68M
Electra Therapeutics Inc.
Sep 23, 2026
Director, Ten Percent Owner
Informative Buy
20.00M
$15.79M
ACADIA Pharmaceuticals
―
Director
―
$28.36M
Acceleron Pharma
Sep 18, 2013
―
Uninformative Buy
―
$1.43M
Amarin
Sep 05, 2012
Director
Uninformative Sell
3.37M
$72.65K
BioCryst
―
Director
―
$0.00
Complete Genomics
―
―
―
―
List of latest transactions for each holding click on a transaction to see Carl Gordon's performance on stock
You May Also Like
Carl Gordon insider profile FAQ
What is the percentage of profitable transactions made by Carl Gordon?
The percentage of profitable transactions made by Carl Gordon is 44%.
What is the average return per transaction made by Carl Gordon?
The average return per transaction made by Carl Gordon is -0.50%.
What stocks does Carl Gordon hold?
Carl Gordon holds: ADRX, PCRX, NTLA, XFOR, ARMO, ALEC, TPTX, PRVL, KROS, ORIC, ACET, KNTE, TERN, IRON, THRX, CMPX, AVBP, MBX, SCTX, BLSM, ETRA, ACAD, XLRN, AMRN, BCRX, ~GNOM stocks.
What was Carl Gordon’s latest transaction?
Carl Gordon latest transaction was an Uninformative Buy of ―.
What was Carl Gordon's most profitable transaction?
Carl Gordon’s most profitable transaction was an Informative Buy of MBX stock on February 19, 2025. The return on the trade was 232.00%.
What is Carl Gordon's role in ADARx Pharmaceuticals?
Carl Gordon's role in ADARx Pharmaceuticals is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.